Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,4 USD | +1,62% | -2,66% | +3,05% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 267 mln. 250 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -94 mln. -87,77 mln. | Nettowinst (verlies) 2025 * | -119 mln. -111 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-3
x | K/w-verhouding 2025 * |
-2,75
x | Werknemers | 59 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,34% |
Recentste transcriptie over Inozyme Pharma, Inc.
1 dag | +1,62% | ||
1 week | -2,66% | ||
Lopende maand | -42,69% | ||
1 maand | -35,25% | ||
3 maanden | -6,79% | ||
6 maanden | +55,67% | ||
Lopend jaar | +3,05% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Axel Bolte
FOU | Founder | 52 | 01-09-15 |
Doug Treco Treco
CEO | Chief Executive Officer | 66 | 01-05-20 |
Director of Finance/CFO | 48 | 31-03-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Doug Treco Treco
CEO | Chief Executive Officer | 66 | 01-05-20 |
Reinaldo Diaz
BRD | Director/Board Member | 70 | 01-01-17 |
Axel Bolte
FOU | Founder | 52 | 01-09-15 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 34 M€ | +2,22% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 4,4 | +1,62% | 15 789 |
25-04-24 | 4,33 | -1,59% | 627 485 |
24-04-24 | 4,4 | 0,00% | 478 912 |
23-04-24 | 4,4 | +0,23% | 742 573 |
22-04-24 | 4,39 | -2,66% | 813 172 |
uitgestelde koers Nasdaq, 26 april 2024 om 15:43 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,05% | 267 mln. | |
+1,80% | 42,59 mld. | |
+7,35% | 40,65 mld. | |
+48,09% | 40,57 mld. | |
-11,96% | 26,77 mld. | |
+8,25% | 24,81 mld. | |
-24,72% | 18,17 mld. | |
+28,50% | 12,05 mld. | |
-2,82% | 11,7 mld. | |
+7,66% | 11,1 mld. |